Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

GlaxoSmithKline (GSK) is conducting a Phase 3 clinical study titled A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, ...

Researchers sought to determine whether subcutaneous isatuximab would be effective for patients with newly diagnosed MM who are ineligible for transplantation.

Cancer survival has doubled in the past half a century, but around 167,000 people still die of the disease in the UK every ...

During a live event, Jorge Monge, MD, discussed real-world evidence on the use of CAR T-cell therapy beyond the trial setting ...

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

PET/CT is a critical tool for MM staging, treatment response monitoring, and the detection of extramedullary disease (EMD), the authors explained. PET/CT has also been found to be a valuable ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Despite decades of research, multiple myeloma remains an incurable disease. A wide array of therapies, such as proteasome ...

Giving patients a whole-body MRI scan can detect minuscule amounts of myeloma, also known as minimal residue disease, even ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...